Stem Cell Marker (Nanog) and Stat-3 Signaling Promote MicroRNA-21 Expression and Chemoresistance in Hyaluronan/CD44-activated Head and Neck Squamous Cell Carcinoma Cells
The binding of HA to CD44 (step 1) promotes a complex formation between Nanog/Stat-3 (also tyrosine phosphorylated Stat-3, p-Stat-3) and CD44 (step 2). Both Nanog and Stat-3 (p-Stat-3) then translocate from the cytosol to the nucleus and interacts with the Stat-3-binding sites located at the upstream promoter/enhancer region of miR-21 (step 4), resulting in miR-21 gene expression and mature miR-21 production (step 5). The resultant miR-21 then functions to downregulate the tumor suppressor protein (PDCD4) (step 6a, indicated by the arrow with solid lines) and promote HNSCC activation leading to IAP (c-IAP-1, c-IAP-2 and XIAP) expression, HNSCC cell anti-apoptosis/survival and chemoresistance (step 7a, indicated by the arrow with solid lines).In direct contrast, treatment of HNSCC cells with an anti-miR-21 inhibitor induces tumor suppressor protein (PDCD4) upregulation (step 6b, indicated by the arrow with dash lines). Subsequently, these changes result in HNSCC cell inactivation including inhibition of IAP (c-IAP-1, c-IAP-2 and XIAP) expression (Fig. 7b, indicated by the arrow with dash lines), stimulation of apoptosis and enhancement of chemosensitivity in HNSCC cells. This newly-discovered Nanog/Stat-3 signaling pathway leading to miR-21 functioning should provide important drug targets for sensitizing tumor cell apoptosis and overcome chemoresistance in HA/CD44-activated head and neck cancer cells.